Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Clean Yield Group

Clean Yield Group trimmed its position in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 11.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 360,091 shares of the company’s stock after selling 46,137 shares during the period. Takeda Pharmaceutical comprises about 1.5% of Clean Yield Group’s portfolio, making the stock its 17th largest holding. Clean Yield Group’s holdings in Takeda Pharmaceutical were worth $4,768,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in TAK. Versant Capital Management Inc acquired a new position in shares of Takeda Pharmaceutical during the 4th quarter valued at about $26,000. Wilmington Savings Fund Society FSB acquired a new position in Takeda Pharmaceutical in the 3rd quarter valued at about $40,000. EverSource Wealth Advisors LLC grew its stake in shares of Takeda Pharmaceutical by 38.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,082 shares of the company’s stock valued at $43,000 after buying an additional 859 shares during the period. BNP Paribas Financial Markets increased its holdings in shares of Takeda Pharmaceutical by 416.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,220 shares of the company’s stock worth $46,000 after buying an additional 2,596 shares during the last quarter. Finally, Smithfield Trust Co raised its position in shares of Takeda Pharmaceutical by 76.9% during the 3rd quarter. Smithfield Trust Co now owns 3,428 shares of the company’s stock valued at $49,000 after buying an additional 1,490 shares during the period. 9.17% of the stock is currently owned by hedge funds and other institutional investors.

Takeda Pharmaceutical Trading Up 0.4 %

Takeda Pharmaceutical stock traded up $0.05 during mid-day trading on Monday, hitting $13.00. The company’s stock had a trading volume of 1,216,596 shares, compared to its average volume of 2,225,471. The stock’s fifty day moving average is $13.46 and its two-hundred day moving average is $13.90. The company has a current ratio of 1.28, a quick ratio of 0.77 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $41.36 billion, a PE ratio of 22.41, a price-to-earnings-growth ratio of 0.25 and a beta of 0.51. Takeda Pharmaceutical Company Limited has a 1 year low of $12.57 and a 1 year high of $15.08.

Takeda Pharmaceutical Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.